<DOC>
	<DOCNO>NCT02771808</DOCNO>
	<brief_summary>Specific aim 1a test hypothesis diabetic patient 2-2 haptoglobin genotype high index postoperative myocardial injury ( creatine kinase MB isoenzyme , Troponin I ) renal injury ( indicate elevate creatinine , cytostatin C glomerular filtration rate ) . Of note , significantly elevate level ( &gt; 5 time upper normal limit ) creatine kinase MB isoenzyme troponins postoperatively associate postoperative myocardial ischemia/infarction predictor short-term long-term mortality cardiac surgery . Specific aim 1b evaluate preoperative postoperative index oxidative stress ( isoprostane f2 alpha malondialdehyde ) evaluate whether patient type 2-2 haptoglobin express increase oxidative stress . The investigator also try correlate whether patient increase oxidative stress elevate index myocardial and/or renal injury Specific aim 1c try evaluate whether patient type 2-2 haptoglobin also increase level inflammatory index ( C-reactive protein , [ interleukin ] IL-1 , IL-2 , IL-6 , TNF [ tumor necrosis factor ] ) try correlate finding postoperative myocardial renal injury . The incidence atrial fibrillation coronary artery bypass graft range 19 % 27 % . The investigator also look correlation type 2-2 haptoglobin incidence post-operative atrial fibrillation .</brief_summary>
	<brief_title>Haptoglobin Polymorphism Determinant Adverse Outcome After Cardiac Surgery Diabetic Patients</brief_title>
	<detailed_description>Diabetes mellitus major risk factor postoperative morbidity mortality cardiac surgery , mainly accelerate atherosclerosis target-organ injury predispose patient increase incidence postoperative morbidity ( limited , postoperative adverse cardiac event , renal injury stroke ) mortality . Over past several year haptoglobin identify risk factor predict development cardiovascular complication diabetic . There 3 major haplotype haptoglobin : 1-1 ; 1-2 2-2 . Several study demonstrate diabetic individual 2-2 genotype 5 fold increase risk develop cardiovascular complication compare diabetic patient non-2-2 haptoglobin genotype . There data literature evaluate whether haptoglobin 2-2 genotype risk factor increase postoperative morbidity and/or mortality cardiac surgery patient DM . Therefore , aim study evaluate whether diabetic patient 2-2 genotype increase risk postoperative morbidity and/or mortality cardiac surgery . Preliminary study diabetic patient demonstrate haptoglobin 2-2 genotype increase risk cardiovascular complication diabetes . Moreover , patient find increase in-hospital mortality acute MI compare diabetic individual 2-2 genotype , also suffer increased incidence post catheterization stent thrombosis compare diabetic 2-2 genotype</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>18 year age old Scheduled elective cardiac surgery pump Diabetic type I type II Informed consent Patients chronic hemolytic disorder ; Patients hemoglobinopathies Enrollment another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>CABG</keyword>
</DOC>